TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and

Yohann Loriot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.